Literature DB >> 16463135

Useful probability considerations in genetics: the goat problem with tigers and other applications of Bayes' theorem.

Konrad Oexle1.   

Abstract

Probabilities or risks may change when new information is available. Common sense frequently fails in assessing this change. In such cases, Bayes' theorem may be applied. It is easy to derive and has abundant applications in biology and medicine. Some examples of the application of Bayes' theorem are presented here, such as carrier risk estimation in X-chromosomal disorders, maximal manifestation probability of a dominant trait with unknown penetrance, combination of genetic and non-genetic information, and linkage analysis. The presentation addresses the non-specialist who asks for valid and consistent explanations. The conclusion to be drawn is that Bayes' theorem is an accessible and helpful tool for probability calculations in genetics.

Entities:  

Mesh:

Year:  2006        PMID: 16463135     DOI: 10.1007/s00431-005-0039-2

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  14 in total

Review 1.  How to model a complex trait. 1. General considerations and suggestions.

Authors:  Konstantin Strauch; Rolf Fimmers; Max P Baur; Thomas F Wienker
Journal:  Hum Hered       Date:  2003       Impact factor: 0.444

2.  Sequential tests for the detection of linkage.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1955-09       Impact factor: 11.025

3.  Theoretical considerations on germline mosaicism in Duchenne muscular dystrophy.

Authors:  T Grimm; B Müller; C R Müller; M Janka
Journal:  J Med Genet       Date:  1990-11       Impact factor: 6.318

4.  Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.

Authors:  E R Hauser; J E Finkelstein; D Valle; S W Brusilow
Journal:  N Engl J Med       Date:  1990-06-07       Impact factor: 91.245

5.  Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.

Authors:  G A Nicholson; D Gardner-Medwin; R J Pennington; J N Walton
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

6.  Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

Authors:  B A McCullough; M Yudkoff; M L Batshaw; J M Wilson; S E Raper; M Tuchman
Journal:  Am J Med Genet       Date:  2000-08-14

7.  Proportions of spontaneous mutations in males and females with ornithine transcarbamylase deficiency.

Authors:  M Tuchman; I Matsuda; A Munnich; S Malcolm; S Strautnieks; T Briede
Journal:  Am J Med Genet       Date:  1995-01-02

8.  Remark on utility and error rates of the allopurinol test in detecting mild ornithine transcarbamylase deficiency.

Authors:  Konrad Oexle; Luisa Bonafé; Beat Steinmann
Journal:  Mol Genet Metab       Date:  2002-05       Impact factor: 4.797

9.  Making the most of multiple measurements in estimating carrier probability in Duchenne muscular dystrophy: the Bayesian incorporation of repeated measurements using logistic discrimination.

Authors:  M E Percy; D F Andrews; P M Brasher; A C Rusk
Journal:  Am J Med Genet       Date:  1987-04

10.  The psychology of the Monty Hall problem: discovering psychological mechanisms for solving a tenacious brain teaser.

Authors:  Stefan Krauss; X T Wang
Journal:  J Exp Psychol Gen       Date:  2003-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.